NONOF:OTCMKTS
Novo Nordisk A/S
$38.34
arrow_downward
-0.09%(-0.035) 1D
Sep 29, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NONOF...
Open
$38.08
High
$38.77
Low
$38.01
Mkt. cap
128.97B
Avg. vol.
132.64K
Volume
85.38K
52-wk high
$64.75
52-wk low
$34.00
Beta
0.63
Shares outstanding
3.39B
No. of employees
67K
Open
$38.08
High
$38.77
Low
$38.01
Mkt. cap
128.97B
Avg. vol.
132.64K
Volume
85.38K
52-wk high
$64.75
52-wk low
$34.00
Beta
0.63
Shares outstanding
3.39B
No. of employees
67K
News stories
From web sources and news partners
The Motley Fool
·
1 hour ago
Novo Nordisk Gives Uninspiring Outlook
Yahoo Finance
·
13 hours ago
Novo to pay Hengrui up to $2.6B for a once-weekly obesity pill
Investing.com
·
15 hours ago
BMO reiterates Novo Nordisk stock rating on Hengrui licensing deal
Pharmaceutical Executive
·
15 hours ago
Roundup: Hengrui Pharma and Novo Enter Exclusive License Agreement for HRS-1596, AstraZeneca Enters Collaboartion with Summit Therapeutics
Profile
Novo is a Danish multinational pharmaceutical company headquartered in Bagsværd. Novo manufactures and markets pharmaceutical products and services, primarily diabetes and obesity medications and devices. The corporation was created in 1989, through a merger of two Danish pharmaceutical companies, which date back to the 1920s.
Novo employs approximately 68,800 people in 80 countries, and markets its products in approximately 170 countries. Novo is controlled by majority shareholder Novo Holdings which holds approximately 28.1% of its shares and a majority of its voting shares.
Novo is a full member of the European Federation of Pharmaceutical Industries and Associations.
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights. It is a leader in the FTSE4Good Index, and the only European company in the top ten.
Novo is the largest pharmaceutical company in Denmark. Wikipedia
About Novo Nordisk A/S
CEOMaziar Mike Doustdar
Employees66.7K
FoundedDec 21, 1923
HeadquartersBagsværd, Capital Region of Denmark, Denmark
SectorPharmaceutical industry
Websitenovonordisk.com